CERUS CORP — Investor Relations & Filings
Filings indexed
1,009
across all filing types
Latest filing
2026-04-30
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CERS
Cerus Corporation is a biomedical products company dedicated to safeguarding the world's blood supply. The company develops and commercializes the INTERCEPT Blood System, a pathogen inactivation technology designed to reduce the risk of transfusion-transmitted infections. The system inactivates a broad spectrum of viruses, bacteria, parasites, and leukocytes in donated blood components. It is used for platelets and plasma, with a system for red blood cells in development. Cerus provides its technology to blood centers and hospitals, aiming to establish a new standard of care for blood safety.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - CERUS CORP (0001020214) (Filer) | 2026-04-30 | English | |
| ARS - CERUS CORP (0001020214) (Filer) | 2026-04-22 | English | |
| DEF 14A - CERUS CORP (0001020214) (Filer) | 2026-04-22 | English | |
| 8-K - CERUS CORP (0001020214) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G - CERUS CORP (0001020214) (Subject) | 2026-03-24 | English | |
| 10-K - CERUS CORP (0001020214) (Filer) | 2026-03-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 39228045 | 10-Q - CERUS CORP (0001020214) (Filer) | 2026-04-30 | English | ||
| 35304984 | ARS - CERUS CORP (0001020214) (Filer) | 2026-04-22 | English | ||
| 35305171 | DEF 14A - CERUS CORP (0001020214) (Filer) | 2026-04-22 | English | ||
| 34915401 | 8-K - CERUS CORP (0001020214) (Filer) | 2026-04-21 | English | ||
| 33035200 | SCHEDULE 13G - CERUS CORP (0001020214) (Subject) | 2026-03-24 | English | ||
| 32885386 | 10-K - CERUS CORP (0001020214) (Filer) | 2026-03-02 | English | ||
| 32885385 | 8-K - CERUS CORP (0001020214) (Filer) | 2026-03-02 | English | ||
| 26298646 | 8-K Filing | 2026-01-23 | English | ||
| 26298636 | 8-K Filing | 2026-01-12 | English | ||
|
2025
6 filings
| |||||
| 10764514 | 4 | 2025-11-26 | English | ||
| 10764525 | Regulatory Filings 2025 | 2025-11-24 | English | ||
| 10764515 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 10764521 | 10-Q | 2025-11-06 | English | ||
| 10764523 | 8-K | 2025-11-06 | English | ||
| 10764526 | 4 | 2025-08-25 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
CERUS CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33349/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33349 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33349 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33349 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33349}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CERUS CORP (id: 33349)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.